Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""passive"" wg kryterium: Temat


Tytuł :
Potential therapeutic options for COVID-19: an update on current evidence.
Autorzy :
Niknam Z; Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Jafari A; Advanced Therapy Medicinal Product (ATMP) Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
Golchin A; Department of Clinical Biochemistry and Applied Cell Sciences, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Danesh Pouya F; Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Nemati M; Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Rezaei-Tavirani M; Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Rasmi Y; Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran. .; Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran. .
Pokaż więcej
Źródło :
European journal of medical research [Eur J Med Res] 2022 Jan 13; Vol. 27 (1), pp. 6. Date of Electronic Publication: 2022 Jan 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunization, Passive*/methods
COVID-19/*drug therapy
COVID-19/*therapy
Antibodies, Monoclonal/therapeutic use ; Antibodies, Neutralizing ; Antiviral Agents/therapeutic use ; Clinical Trials as Topic ; Dietary Supplements ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; Pandemics ; SARS-CoV-2 ; Treatment Outcome
SCR Protocol :
COVID-19 drug treatment; COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Vax-Plasma in Patients With Refractory COVID-19.
Autorzy :
Ordaya EE; Mayo Clinic, Rochester, MN.
Abu Saleh OM; Mayo Clinic, Rochester, MN.
Stubbs JR; Mayo Clinic, Rochester, MN.
Joyner MJ; Mayo Clinic, Rochester, MN.
Pokaż więcej
Źródło :
Mayo Clinic proceedings [Mayo Clin Proc] 2022 Jan; Vol. 97 (1), pp. 186-189. Date of Electronic Publication: 2021 Nov 12.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Immunization, Passive*
COVID-19/*drug therapy
COVID-19/*therapy
COVID-19/diagnostic imaging ; Humans ; Male ; Middle Aged ; Treatment Outcome
SCR Protocol :
COVID-19 drug treatment; COVID-19 serotherapy
Raport
Tytuł :
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial.
Autorzy :
Menichetti F; Infectious Disease Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.
Popoli P; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Puopolo M; Department of Neuroscience, Istituto Superiore di Sanità, Rome, Italy.
Spila Alegiani S; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Tiseo G; Infectious Disease Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.
Bartoloni A; Infectious and Tropical Diseases Unit, Florence Department of Medicine, Careggi University Hospital, Florence, Italy.
De Socio GV; Clinic of Infectious Diseases, 'Santa Maria della Misericordia' Hospital, University of Perugia, Perugia, Italy.
Luchi S; Infectious Disease Unit, Hospital of Lucca, Lucca, Italy.
Blanc P; Infectious Diseases, Ospedale S. Maria Annunziata, Firenze, Italy.
Puoti M; University of Milano-Bicocca School of Medicine, Milan, Italy.; Azienda socio sanitaria territorial (ASST) Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Toschi E; Research Coordination and Support Service (CoRi), Istituto Superiore di Sanità, Rome, Italy.
Massari M; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Palmisano L; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
Marano G; Italian National Blood Centre, Rome, Italy.
Chiamenti M; Unit of Infectious Diseases, Carlo Poma Hospital, Mantova, Italy.
Martinelli L; Internal Medicine, Unità Sanitaria Locale (USL)-Umbria 1, Ospedale Città di Castello, Città di Castello, Italy.
Franchi S; Internal Medicine, Unità Sanitaria Locale (USL)-Umbria 1, Ospedale Città di Castello, Città di Castello, Italy.
Pallotto C; Infectious Diseases Unit, San Giuseppe Hospital, Azienda USL Toscana Centro, Empoli, Italy.
Suardi LR; Infectious Disease Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.; Infectious Diseases Unit, San Giuseppe Hospital, Azienda USL Toscana Centro, Empoli, Italy.
Luciani Pasqua B; Centro Regionale Sangue, Servizio Immunotrasfusionale, Azienda Ospedaliera di Perugia, Perugia, Italy.
Merli M; Azienda socio sanitaria territorial (ASST) Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Fabiani P; Internal Medicine, Ospedale Unico della Versilia, Lido di Camaiore, Italy.
Bertolucci L; Internal Medicine, Ospedale Unico della Versilia, Lido di Camaiore, Italy.
Borchi B; Infectious and Tropical Diseases Unit, Florence Department of Medicine, Careggi University Hospital, Florence, Italy.
Modica S; Infectious and Tropical Diseases Unit, Florence Department of Medicine, Careggi University Hospital, Florence, Italy.
Moneta S; Infectious Disease Unit, Hospital of Lucca, Lucca, Italy.
Marchetti G; Infectious Diseases Unit, Department of Health Sciences, ASST Santi Paolo e Carlo University Hospital, Milan, Italy.
d'Arminio Monforte A; Infectious Diseases Unit, Department of Health Sciences, ASST Santi Paolo e Carlo University Hospital, Milan, Italy.
Stoppini L; Internal Medicine, Ospedale di Foligno, Foligno, Italy.
Ferracchiato N; Internal Medicine, Ospedale di Foligno, Foligno, Italy.
Piconi S; Infectious Diseases, Azienda Ospedaliera di Lecco, Lecco, Italy.
Fabbri C; Infectious Diseases, Ospedale San Jacopo, Pistoia, Italy.
Beccastrini E; Cell Therapy and Transfusion Medicine, Careggi University Hospital, Florence, Italy.
Saccardi R; Cell Therapy and Transfusion Medicine, Careggi University Hospital, Florence, Italy.
Giacometti A; Azienda Ospedaliera Universitaria, Ospedali Riuniti di Ancona, Ancona, Italy.
Esperti S; Infectious Diseases, Ospedale S. Maria Annunziata, Firenze, Italy.
Pierotti P; Infectious Diseases, Ospedale S. Maria Annunziata, Firenze, Italy.
Bernini L; Division of Infectious Diseases, Arezzo Hospital, Arezzo, Italy.
Bianco C; Division of Infectious Diseases, Arezzo Hospital, Arezzo, Italy.
Benedetti S; Clinic of Infectious Diseases, 'Santa Maria della Misericordia' Hospital, University of Perugia, Perugia, Italy.
Lanzi A; Clinic of Infectious Diseases, 'Santa Maria della Misericordia' Hospital, University of Perugia, Perugia, Italy.
Bonfanti P; Department of Infectious Diseases, ASST Monza, University of Milano-Bicocca, Milan, Italy.
Massari M; Infectious Disease Unit, Azienda USL-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) di Reggio Emilia, Reggio Emilia, Italy.
Sani S; Infectious Diseases, Livorno Hospital, Livorno, Italy.
Saracino A; Division of Infectious Diseases, Bari University Hospital, Bari, Italy.
Castagna A; Infectious Diseases, IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele, Milan, Italy.
Trabace L; Department of Experimental and Clinical Medicine, University of Foggia, Foggia, Italy.
Lanza M; North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
Focosi D; North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
Mazzoni A; Division of Transfusion Medicine and Transplant Biology, Pisa University Hospital, Pisa, Italy.
Pistello M; Division of Virology, University Hospital of Pisa, Retrovirus Center, Department of Translational Research, University of Pisa, Pisa, Italy.
Falcone M; Infectious Disease Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.
Pokaż więcej
Corporate Authors :
TSUNAMI Study group
Źródło :
JAMA network open [JAMA Netw Open] 2021 Nov 01; Vol. 4 (11), pp. e2136246. Date of Electronic Publication: 2021 Nov 01.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Hospital Mortality*
Hospitalization*
Immunization, Passive*
Plasma*
Respiratory Insufficiency*
COVID-19/*therapy
Aged ; COVID-19/complications ; COVID-19/mortality ; Disease Progression ; Female ; Humans ; Italy ; Male ; Middle Aged ; Prospective Studies ; SARS-CoV-2 ; Severity of Illness Index ; Standard of Care
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Prevalence of failure of passive transfer of immunity in dairy calves in a Mediterranean pasture-based production system of the south-west region of Western Australia.
Autorzy :
Aleri JW; School of Veterinary Medicine, College of Science, Health, Engineering and Education, Murdoch University, 90 South Street, Murdoch 6150, WA, Australia. Electronic address: .
Gogoi-Tiwari J; School of Veterinary Medicine, College of Science, Health, Engineering and Education, Murdoch University, 90 South Street, Murdoch 6150, WA, Australia.
Tiwari HK; Sydney School of Veterinary Science, The University of Sydney, Camden 2570, New South Wales, Australia.
Fisher AD; Faculty of Veterinary and Agricultural Sciences, University of Melbourne, 250 Princes Highway, Werribee, Victoria 3030, Australia; Animal Welfare Science Centre, University of Melbourne, Victoria 3010, Australia.
Waichigo FW; Brunswick Veterinary Services, 27 Ommaney Road, Brunswick Junction, WA 6224, Australia.
Robertson ID; School of Veterinary Medicine, College of Science, Health, Engineering and Education, Murdoch University, 90 South Street, Murdoch 6150, WA, Australia; Hubei International Scientific and Technological Cooperation Base of Veterinary Epidemiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, PR China.
Pokaż więcej
Źródło :
Research in veterinary science [Res Vet Sci] 2021 Oct; Vol. 139, pp. 121-126. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article
MeSH Terms :
Cattle*/immunology
Colostrum*
Immunization, Passive*/veterinary
Immunoglobulin G*
Animals ; Animals, Newborn ; Cross-Sectional Studies ; Female ; Pregnancy ; Prevalence ; Western Australia/epidemiology
Czasopismo naukowe
Tytuł :
Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges.
Autorzy :
Gong S; Texas Biomedical Research Institute, San Antonio, TX, United States.; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.
Lakhashe SK; Texas Biomedical Research Institute, San Antonio, TX, United States.
Hariraju D; Texas Biomedical Research Institute, San Antonio, TX, United States.; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.
Scinto H; Texas Biomedical Research Institute, San Antonio, TX, United States.; Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, United States.
Lanzavecchia A; Institute for Research in Biomedicine, Bellinzona, Switzerland.; Humabs BioMed, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Cameroni E; Institute for Research in Biomedicine, Bellinzona, Switzerland.; Humabs BioMed, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Corti D; Institute for Research in Biomedicine, Bellinzona, Switzerland.; Humabs BioMed, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Ratcliffe SJ; University of Pennsylvania, Philadelphia, PA, United States.
Rogers KA; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.; Department of Biology, University of Louisiana at Lafayette, Lafayette, LA, United States.
Xiao P; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.
Fontenot J; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.
Villinger F; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.; Department of Biology, University of Louisiana at Lafayette, Lafayette, LA, United States.
Ruprecht RM; Texas Biomedical Research Institute, San Antonio, TX, United States.; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.; Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, United States.; Department of Biology, University of Louisiana at Lafayette, Lafayette, LA, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Aug 03; Vol. 12, pp. 705592. Date of Electronic Publication: 2021 Aug 03 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Immunization, Passive*
Simian Acquired Immunodeficiency Syndrome*/immunology
Simian Acquired Immunodeficiency Syndrome*/prevention & control
Antibodies, Monoclonal/*pharmacology
Antibodies, Neutralizing/*pharmacology
HIV Antibodies/*pharmacology
HIV-1/*immunology
Immunity, Mucosal/*drug effects
Simian Immunodeficiency Virus/*immunology
Animals ; Antibodies, Monoclonal/immunology ; Antibodies, Neutralizing/immunology ; HIV Antibodies/immunology ; Macaca mulatta ; Pilot Projects
Czasopismo naukowe
Tytuł :
Antiallergic Activity of 6-Deoxy-2- O -methyl-6-( N -hexadecanoyl)amino-l-ascorbic Acid.
Autorzy :
Miura K; LAIMU Corporation, 3-6-12 Shinyokohama, Kohoku-ku, Yokohama, Kanagawa 222-0033, Japan.
Matsuno H; Faculty of Life and Environmental Sciences, Prefectural University of Hiroshima, 5562 Nanatsuka-cho, Shobara, Hiroshima 727-0023, Japan.
Iwaoka Y; Faculty of Health and Welfare Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama 719-1197, Japan.
Ito H; Faculty of Health and Welfare Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama 719-1197, Japan.
Tai A; Faculty of Life and Environmental Sciences, Prefectural University of Hiroshima, 5562 Nanatsuka-cho, Shobara, Hiroshima 727-0023, Japan.; Graduate School of Technology, Industrial and Social Sciences, Tokushima University, 2-1 Minamijosanjima-cho, Tokushima 770-8513, Japan.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2021 Aug 03; Vol. 26 (15). Date of Electronic Publication: 2021 Aug 03.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Allergic Agents*/chemical synthesis
Anti-Allergic Agents*/chemistry
Anti-Allergic Agents*/pharmacology
Ascorbic Acid*/analogs & derivatives
Ascorbic Acid*/chemical synthesis
Ascorbic Acid*/chemistry
Ascorbic Acid*/pharmacology
Passive Cutaneous Anaphylaxis*
Cell Degranulation/*drug effects
Hypersensitivity/*drug therapy
Animals ; Disease Models, Animal ; Mice
Czasopismo naukowe
Tytuł :
Convalescent plasma treatment for patients of 80 years and older with COVID-19 pneumonia.
Autorzy :
Romon I; Hematology and Hemotherapy Service, Hospital Universitario Marqués de Valdecilla, Avenida Valdecilla, s/n, 39008, Santander, Spain. .
Dominguez-Garcia JJ; Hematology and Hemotherapy Service, Hospital Universitario Marqués de Valdecilla, Avenida Valdecilla, s/n, 39008, Santander, Spain.
Arroyo JL; Banco de Sangre y Tejidos de Cantabria, 39121, Liencres, Spain.
Suberviola B; Intensive Care Service, Hospital Universitario Marqués de Valdecilla, 39008, Santander, Spain.
Cabezón I; Infectious Diseases Service, Hospital Universitario Marqués de Valdecilla, 39008, Santander, Spain.
Abascal B; Pneumology Service, Hospital Universitario Marqués de Valdecilla, 39008, Santander, Spain.
Baldeón C; Internal Medicine Service, Hospital Universitario Marqués de Valdecilla, 39008, Santander, Spain.
Cuesta A; Haematology Service, Hospital de Sierrallana, 39300, Torrelavega, Spain.
Portilla R; Internal Medicine Service, Hospital de Sierrallana, 39300, Torrelavega, Spain.
Casuso E; Internal Medicine Service, Hospital de Laredo, 39770, Laredo, Spain.
Ocio E; Hematology and Hemotherapy Service, Hospital Universitario Marqués de Valdecilla, Avenida Valdecilla, s/n, 39008, Santander, Spain.
Briz M; Hematology and Hemotherapy Service, Hospital Universitario Marqués de Valdecilla, Avenida Valdecilla, s/n, 39008, Santander, Spain.
Pokaż więcej
Źródło :
BMC geriatrics [BMC Geriatr] 2021 Oct 18; Vol. 21 (1), pp. 566. Date of Electronic Publication: 2021 Oct 18.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/therapy
Immunization, Passive*
Aged, 80 and over ; Humans ; Retrospective Studies ; Spain ; Treatment Outcome
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Early Convalescent Plasma Therapy and Mortality Among US Veterans Hospitalized With Nonsevere COVID-19: An Observational Analysis Emulating a Target Trial.
Autorzy :
Cho K; Massachusetts Veterans Epidemiology Research and Information Center, Department of Veterans Affairs Office of Research and Development, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Keithly SC; Seattle Epidemiologic Research and Information Center, Department of Veterans Affairs Office of Research and Development, Seattle, Washington, USA.
Kurgansky KE; Massachusetts Veterans Epidemiology Research and Information Center, Department of Veterans Affairs Office of Research and Development, Boston, Massachusetts, USA.
Madenci AL; Departments of Epidemiology and Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Gerlovin H; Massachusetts Veterans Epidemiology Research and Information Center, Department of Veterans Affairs Office of Research and Development, Boston, Massachusetts, USA.
Marucci-Wellman H; Massachusetts Veterans Epidemiology Research and Information Center, Department of Veterans Affairs Office of Research and Development, Boston, Massachusetts, USA.
Doubleday A; Seattle Epidemiologic Research and Information Center, Department of Veterans Affairs Office of Research and Development, Seattle, Washington, USA.
Thomas ER; Seattle Epidemiologic Research and Information Center, Department of Veterans Affairs Office of Research and Development, Seattle, Washington, USA.
Park Y; Massachusetts Veterans Epidemiology Research and Information Center, Department of Veterans Affairs Office of Research and Development, Boston, Massachusetts, USA.
Ho YL; Massachusetts Veterans Epidemiology Research and Information Center, Department of Veterans Affairs Office of Research and Development, Boston, Massachusetts, USA.
Sugimoto JD; Seattle Epidemiologic Research and Information Center, Department of Veterans Affairs Office of Research and Development, Seattle, Washington, USA.; Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Moore KP; Seattle Epidemiologic Research and Information Center, Department of Veterans Affairs Office of Research and Development, Seattle, Washington, USA.
Peterson AC; Seattle Epidemiologic Research and Information Center, Department of Veterans Affairs Office of Research and Development, Seattle, Washington, USA.
Hoag C; Massachusetts Veterans Epidemiology Research and Information Center, Department of Veterans Affairs Office of Research and Development, Boston, Massachusetts, USA.
Gupta K; Boston Healthcare System, Department of Veterans Affairs, Boston, Massachusetts, USA.; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Jeans K; Department of Veterans Affairs Office of Research and Development, Washington, District of Columbia, USA.
Klote M; Department of Veterans Affairs Office of Research and Development, Washington, District of Columbia, USA.
Ramoni R; Department of Veterans Affairs Office of Research and Development, Washington, District of Columbia, USA.
Huang GD; Department of Veterans Affairs Office of Research and Development, Washington, District of Columbia, USA.
Casas JP; Massachusetts Veterans Epidemiology Research and Information Center, Department of Veterans Affairs Office of Research and Development, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Gagnon DR; Massachusetts Veterans Epidemiology Research and Information Center, Department of Veterans Affairs Office of Research and Development, Boston, Massachusetts, USA.; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
Hernán MA; Departments of Epidemiology and Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Smith NL; Seattle Epidemiologic Research and Information Center, Department of Veterans Affairs Office of Research and Development, Seattle, Washington, USA.; Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.
Gaziano JM; Massachusetts Veterans Epidemiology Research and Information Center, Department of Veterans Affairs Office of Research and Development, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2021 Sep 17; Vol. 224 (6), pp. 967-975.
Typ publikacji :
Clinical Trial; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood Component Transfusion*
Immunization, Passive*
Plasma*
COVID-19/*mortality
COVID-19/*therapy
Adult ; Aged ; Aged, 80 and over ; Female ; Hospitalization ; Humans ; Male ; Middle Aged ; Treatment Outcome ; United States/epidemiology ; Veterans ; Young Adult
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis.
Autorzy :
Phelps M; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States.
Balazs AB; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Sep 15; Vol. 12, pp. 734304. Date of Electronic Publication: 2021 Sep 15 (Print Publication: 2021).
Typ publikacji :
Journal Article; Review
MeSH Terms :
Genetic Therapy*
Genetic Vectors*
Immunization, Passive*
Broadly Neutralizing Antibodies/*genetics
Dependovirus/*genetics
HIV/*immunology
HIV Infections/*therapy
Animals ; Antibody-Dependent Cell Cytotoxicity ; Broadly Neutralizing Antibodies/biosynthesis ; Broadly Neutralizing Antibodies/immunology ; Complement Activation ; HIV/pathogenicity ; HIV Infections/immunology ; HIV Infections/virology ; Host-Pathogen Interactions ; Humans ; Phagocytosis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study.
Autorzy :
Cho Y; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Sohn Y; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Hyun J; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Baek Y; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Kim M; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Kim J; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Ahn J; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Jeong S; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Ku N; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Yeom JS; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Ahn M; Department of Internal Medicine, Seoul Medical Center, Seoul, Korea.
Oh D; Department of Internal Medicine, Seoul Medical Center, Seoul, Korea.
Choi J; Department of Internal Medicine, Seoul Medical Center, Seoul, Korea.
Kim S; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
Lee K; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Song Y; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Choi J; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło :
Yonsei medical journal [Yonsei Med J] 2021 Sep; Vol. 62 (9), pp. 799-805.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/therapy
Immunization, Passive*
Aged ; Critical Illness ; Humans ; Retrospective Studies ; United States
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy.
Autorzy :
Goyal NA; Department of Neurology, MDA ALS and Neuromuscular Center, University of California, Irvine, California, USA.
Karam C; Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sheikh KA; Department of Neurology, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Dimachkie MM; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Pokaż więcej
Źródło :
Muscle & nerve [Muscle Nerve] 2021 Sep; Vol. 64 (3), pp. 243-254. Date of Electronic Publication: 2021 Jul 14.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Immunization, Passive*
Immunoglobulin G/*therapeutic use
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/*drug therapy
Humans ; Immunoglobulin G/administration & dosage ; Infusions, Subcutaneous
Czasopismo naukowe
Tytuł :
Epstein-Barr virus (EBV) hyperimmune globulin isolated from donors with high gp350 antibody titers protect humanized mice from challenge with EBV.
Autorzy :
Kim J; Medical Virology Section, Laboratory of Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, 20740, USA.
Bu W; Medical Virology Section, Laboratory of Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Mine S; Medical Virology Section, Laboratory of Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Tariq Z; Medical Virology Section, Laboratory of Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Nguyen H; Medical Virology Section, Laboratory of Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Wang Y; Clinical Services Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Tolman C; ADMA Biologics, Boca Raton, FL, 33487, USA.
Mond J; ADMA Biologics, Boca Raton, FL, 33487, USA.
Cohen JI; Medical Virology Section, Laboratory of Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. Electronic address: .
Pokaż więcej
Źródło :
Virology [Virology] 2021 Sep; Vol. 561, pp. 80-86. Date of Electronic Publication: 2021 Jun 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Immunization, Passive*
Antibodies, Neutralizing/*therapeutic use
Antibodies, Viral/*therapeutic use
Epstein-Barr Virus Infections/*prevention & control
Epstein-Barr Virus Infections/*therapy
Herpesvirus 4, Human/*immunology
Viral Matrix Proteins/*immunology
Animals ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; B-Lymphocytes/immunology ; Blood Donors ; Epstein-Barr Virus Infections/virology ; Herpesvirus 4, Human/physiology ; Mice ; Viral Load
Czasopismo naukowe
Tytuł :
Antibody activities in hyperimmune plasma against the Rhodococcus equi virulence -associated protein A or poly-N-acetyl glucosamine are associated with protection of foals against rhodococcal pneumonia.
Autorzy :
Kahn SK; Department of Large Animal Clinical Sciences, Equine Infectious Disease Laboratory, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX, United States of America.
Cywes-Bentley C; Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States of America.
Blodgett GP; 6666 Ranch, Guthrie, TX, United States of America.
Canaday NM; 6666 Ranch, Guthrie, TX, United States of America.
Turner-Garcia CE; Lazy E Ranch, Guthrie, OK, United States of America.
Vinacur M; Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States of America.
Cortez-Ramirez SC; Department of Large Animal Clinical Sciences, Equine Infectious Disease Laboratory, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX, United States of America.
Sutter PJ; Mg Biologics, Inc., Ames, IA, United States of America.
Meyer SC; Mg Biologics, Inc., Ames, IA, United States of America.
Bordin AI; Department of Large Animal Clinical Sciences, Equine Infectious Disease Laboratory, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX, United States of America.
Vlock DR; Alopexx Inc., Concord, MA, United States of America.
Pier GB; Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States of America.
Cohen ND; Department of Large Animal Clinical Sciences, Equine Infectious Disease Laboratory, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Aug 26; Vol. 16 (8), pp. e0250133. Date of Electronic Publication: 2021 Aug 26 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Acetylglucosamine/*immunology
Actinomycetales Infections/*veterinary
Antibodies, Bacterial/*therapeutic use
Bacterial Proteins/*immunology
Horse Diseases/*prevention & control
Immunization, Passive/*veterinary
Pneumonia, Bacterial/*veterinary
Rhodococcus equi/*immunology
Actinomycetales Infections/immunology ; Actinomycetales Infections/microbiology ; Actinomycetales Infections/prevention & control ; Animals ; Animals, Newborn/immunology ; Animals, Newborn/microbiology ; Antibodies, Bacterial/immunology ; Female ; Horse Diseases/immunology ; Horse Diseases/microbiology ; Horses/immunology ; Horses/microbiology ; Immunization, Passive/methods ; Male ; Pneumonia, Bacterial/immunology ; Pneumonia, Bacterial/microbiology ; Pneumonia, Bacterial/prevention & control
Czasopismo naukowe
Tytuł :
What convalescent plasma in treating severe acute respiratory infections of viral aetiology can hint for COVID-19? Evidence from a meta-analysis.
Autorzy :
Zeng J; Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Organ transplantation center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Yin S; Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Organ transplantation center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Du X; Organ transplantation center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Song T; Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Organ transplantation center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. Electronic address: .
Lin T; Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Organ transplantation center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. Electronic address: .
Pokaż więcej
Źródło :
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine [Transfus Clin Biol] 2021 Aug; Vol. 28 (3), pp. 321-329. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Blood Component Transfusion*
Convalescence*
Immunization, Passive*
Plasma*
SARS-CoV-2*
COVID-19/*therapy
Respiratory Tract Infections/*therapy
Acute Disease ; COVID-19/blood ; COVID-19/mortality ; Extracorporeal Membrane Oxygenation/statistics & numerical data ; Humans ; Length of Stay/statistics & numerical data ; Procedures and Techniques Utilization ; Respiration, Artificial/statistics & numerical data ; Respiratory Tract Infections/virology
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV Infection.
Autorzy :
Ossami Saidy RR; Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Sud I; Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Eurich F; Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Aydin M; Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Postel MP; Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Dobrindt EM; Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Pratschke J; Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Eurich D; Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Pokaż więcej
Źródło :
Viruses [Viruses] 2021 May 13; Vol. 13 (5). Date of Electronic Publication: 2021 May 13.
Typ publikacji :
Journal Article
MeSH Terms :
Immunization, Passive*
Coinfection/*prevention & control
Hepatitis B/*prevention & control
Hepatitis B virus/*immunology
Hepatitis D/*prevention & control
Hepatitis Delta Virus/*immunology
Liver Transplantation/*adverse effects
Biomarkers ; Coinfection/epidemiology ; Female ; Hepatitis B/epidemiology ; Hepatitis D/epidemiology ; Humans ; Immunohistochemistry ; Liver Transplantation/statistics & numerical data ; Male ; Postoperative Period ; Prognosis ; Recurrence
Czasopismo naukowe
Tytuł :
S100A4 Is Critical for a Mouse Model of Allergic Asthma by Impacting Mast Cell Activation.
Autorzy :
Wu T; Center for Clinical Laboratory, Affiliated Hospital of Guizhou Medical University, Guiyang, China.; School for Clinical Laboratory, Guizhou Medical University, Guiyang, China.
Ma L; School for Clinical Laboratory, Guizhou Medical University, Guiyang, China.
Jin X; School for Clinical Laboratory, Guizhou Medical University, Guiyang, China.
He J; School for Clinical Laboratory, Guizhou Medical University, Guiyang, China.
Chen K; School for Clinical Laboratory, Guizhou Medical University, Guiyang, China.
Zhang D; School for Clinical Laboratory, Guizhou Medical University, Guiyang, China.
Yuan R; Center for Clinical Laboratory, Affiliated Hospital of Guizhou Medical University, Guiyang, China.; School for Clinical Laboratory, Guizhou Medical University, Guiyang, China.
Yang J; Center for Pediatric Medicine, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Zhong Q; School for Clinical Laboratory, Guizhou Medical University, Guiyang, China.
Zhou H; School for Clinical Laboratory, Guizhou Medical University, Guiyang, China.
Xiang Z; Department of Health Technology and Informatics, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong, China.
Fang Y; Center for Clinical Laboratory, Affiliated Hospital of Guizhou Medical University, Guiyang, China.; School for Clinical Laboratory, Guizhou Medical University, Guiyang, China.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Jul 22; Vol. 12, pp. 692733. Date of Electronic Publication: 2021 Jul 22 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Degranulation*
Passive Cutaneous Anaphylaxis*
Asthma/*metabolism
Lung/*metabolism
Mast Cells/*metabolism
S100 Calcium-Binding Protein A4/*metabolism
Animals ; Asthma/genetics ; Asthma/immunology ; Cells, Cultured ; Cytokines/metabolism ; Disease Models, Animal ; Immunity, Humoral ; Immunoglobulin E/metabolism ; Immunoglobulin G/metabolism ; Immunologic Memory ; Lung/immunology ; Male ; Mast Cells/immunology ; Mice, Inbred C57BL ; Mice, Knockout ; Ovalbumin ; S100 Calcium-Binding Protein A4/genetics ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism
Czasopismo naukowe
Tytuł :
Minimal important differences and self-identifying treatment response in chronic inflammatory demyelinating polyneuropathy.
Autorzy :
Rajabally YA; Inflammatory Neuropathy Clinic, Department of Neurology, University Hospitals Birmingham, Birmingham, UK.; Aston Medical School, Aston University, Birmingham, UK.
Afzal S; Inflammatory Neuropathy Clinic, Department of Neurology, University Hospitals Birmingham, Birmingham, UK.
Ghasemi M; Inflammatory Neuropathy Clinic, Department of Neurology, University Hospitals Birmingham, Birmingham, UK.
Pokaż więcej
Źródło :
Muscle & nerve [Muscle Nerve] 2021 Jul; Vol. 64 (1), pp. 37-42. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Self Report*
Immunization, Passive/*trends
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/*diagnosis
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/*therapy
Adult ; Aged ; Female ; Humans ; Immunization, Passive/methods ; Male ; Middle Aged ; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/immunology ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Antibodies Elicited in Response to a Single Cycle Glycoprotein D Deletion Viral Vaccine Candidate Bind C1q and Activate Complement Mediated Neutralization and Cytolysis.
Autorzy :
Visciano ML; Departments of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Mahant AM; Departments of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Pierce C; Departments of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Hunte R; Departments of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Herold BC; Departments of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Pokaż więcej
Źródło :
Viruses [Viruses] 2021 Jun 30; Vol. 13 (7). Date of Electronic Publication: 2021 Jun 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Complement Activation*
Immunization, Passive*
Antibodies, Viral/*metabolism
Complement C1q/*metabolism
Viral Envelope Proteins/*genetics
Viral Envelope Proteins/*immunology
Viral Vaccines/*genetics
Viral Vaccines/*immunology
Adjuvants, Immunologic ; Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Antibody-Dependent Cell Cytotoxicity ; Complement C1q/genetics ; Complement C1q/immunology ; Female ; Gene Deletion ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Knockout ; Phagocytosis ; Vaccination ; Viral Envelope Proteins/metabolism ; Viral Vaccines/administration & dosage
Czasopismo naukowe
Tytuł :
Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.
Autorzy :
Jacque E; LFB Biotechnologies, Les Ulis, France.
Chottin C; Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Laubreton D; Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Nogre M; LFB Biotechnologies, Les Ulis, France.
Ferret C; Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
de Marcos S; LFB Biotechnologies, Les Ulis, France.
Baptista L; LFB Biotechnologies, Les Ulis, France.
Drajac C; Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Mondon P; LFB Biotechnologies, Les Ulis, France.
De Romeuf C; LFB Biotechnologies, Les Ulis, France.
Rameix-Welti MA; Université Paris-Saclay, UVSQ, Inserm, Infection et inflammation, U1173, Montigny-Le-Bretonneux, France.; AP-HP, Hôpital Ambroise Paré, Laboratoire de Microbiologie, Boulogne-Billancourt, France.
Eléouët JF; Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Chtourou S; LFB Biotechnologies, Les Ulis, France.
Riffault S; Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Perret G; LFB Biotechnologies, Les Ulis, France.
Descamps D; Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Jun 07; Vol. 12, pp. 683902. Date of Electronic Publication: 2021 Jun 07 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Immunization, Passive*
Antibodies, Viral/*administration & dosage
Immunoglobulin G/*administration & dosage
Respiratory Syncytial Virus Infections/*prevention & control
Respiratory Syncytial Virus, Human/*immunology
Administration, Intranasal ; Animals ; Antibodies, Viral/immunology ; Antibodies, Viral/isolation & purification ; Disease Models, Animal ; Humans ; Immunoglobulin G/immunology ; Immunoglobulin G/isolation & purification ; Lung/drug effects ; Lung/virology ; Neutralization Tests ; Respiratory Syncytial Virus Infections/virology ; Turbinates/drug effects ; Turbinates/virology ; Viral Fusion Proteins/immunology ; Virus Replication/drug effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies